Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2007

Open Access 01-12-2007 | Research article

A case-control study on risk factors for early-onset respiratory tract infection in patients admitted in ICU

Authors: Teresa C Cardoso, Luís M Lopes, António H Carneiro

Published in: BMC Pulmonary Medicine | Issue 1/2007

Login to get access

Abstract

Background

Respiratory tract infections are common in intensive care units (ICU), with incidences reported from 10 to 65%, and case fatality rates over 20% in pneumonia. This study was designed to identify risk factors for the development of an early onset respiratory tract infection (ERI) and to review the microbiological profile and the effectiveness of first intention antibiotic therapy.

Methods

Case-control, retrospective clinical study of the patients admitted to the Intensive Care Unit (ICU) of our hospital, a teaching and tertiary care facility, from January to September 2000 who had a respiratory tract infection diagnosed in the first 5 days of hospital stay.

Results

Of the 385 patients admitted to our unit: 129 (33,5%) had a diagnosis of ERI and 86 patients were admitted to the control group. Documented aspiration (adjusted OR = 5,265; 95% CI = 1,155 – 24,007) and fractured ribs (adjusted OR = 12,150; 95% CI = 1,571 – 93,941) were found to be independent risk factors for the development of ERI (multiple logistic regression model performed with the diagnostic group as dependent variable and adjusted for age, sex, SAPS II, documented aspiration, non-elective oro-tracheal intubation (OTI), fractured ribs, pneumothorax and pleural effusion).
A total of 78 organisms were isolated in 61 patients (47%). The normal flora of the upper airway (Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenza and Moraxella catharralis) accounted for 72% of all isolations achieved, polimicrobian infections were responsible for 25% of all microbiological documented infections. First intention treatment was, in 62% of the patients, the association amoxacillin+clavulanate, being effective in 75% of the patients to whom it was administered.
The patients with ERI needed more days of OTI (6 vs 2, p < 0,001) and mechanical ventilation (6 vs 2, p < 0,001) and had a longer ICU (7 vs 2, p < 0,001) and hospital length of stay (17 vs 11, p = 0,018), when compared with controls.

Conclusion

In this study documented tracheobronchial aspiration and fractured ribs were identified as independent risk factors for ERI. Microbiological profile was dominated by sensitive micro-organisms. The choice amoxacilin+clavulanate revealed to be a good option with an effectiveness rate of 77% in the patients in whom it was used.
Literature
1.
go back to reference Ibrahim EH, Ward S, Sherman G, Kollef MH: "A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting". Chest. 2000, 117 (5): 1434-42. 10.1378/chest.117.5.1434.CrossRefPubMed Ibrahim EH, Ward S, Sherman G, Kollef MH: "A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting". Chest. 2000, 117 (5): 1434-42. 10.1378/chest.117.5.1434.CrossRefPubMed
2.
go back to reference American Thoracic Society: "Guidelines for the management of adults with hospital-acquired, ventilator-associated and health-care associated pneumonia". Am J Respir Crit Care Med. 2005, 171: 388-416. 10.1164/rccm.200405-644ST.CrossRef American Thoracic Society: "Guidelines for the management of adults with hospital-acquired, ventilator-associated and health-care associated pneumonia". Am J Respir Crit Care Med. 2005, 171: 388-416. 10.1164/rccm.200405-644ST.CrossRef
3.
go back to reference Cook DJ, Kollef MH: "Risk factors for ICU-acquired pneumonia". JAMA. 1998, 279 (20): 1605-6. 10.1001/jama.279.20.1605.CrossRefPubMed Cook DJ, Kollef MH: "Risk factors for ICU-acquired pneumonia". JAMA. 1998, 279 (20): 1605-6. 10.1001/jama.279.20.1605.CrossRefPubMed
4.
go back to reference Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPSII) based on a European/North American multicenter study. JAMA. 1993, 270: 2957-2963. 10.1001/jama.270.24.2957.CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPSII) based on a European/North American multicenter study. JAMA. 1993, 270: 2957-2963. 10.1001/jama.270.24.2957.CrossRefPubMed
5.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-829. 10.1097/00003246-198510000-00009.CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-829. 10.1097/00003246-198510000-00009.CrossRefPubMed
6.
go back to reference Baker AM, Meredith JW, Haponik EF: "Pneumonia in intubated trauma patients. Microbiology and outcomes". Am J Respir Crit Care Med. 1996, 153 (1): 343-9.CrossRefPubMed Baker AM, Meredith JW, Haponik EF: "Pneumonia in intubated trauma patients. Microbiology and outcomes". Am J Respir Crit Care Med. 1996, 153 (1): 343-9.CrossRefPubMed
7.
go back to reference Mosconi P, Langer M, Cigada M, Mandelli M: "Epidemiology and risk factors of pneumonia in critically ill patients". Eur J Epidemiol. 1991, 7: 320-327. 10.1007/BF00144995.CrossRefPubMed Mosconi P, Langer M, Cigada M, Mandelli M: "Epidemiology and risk factors of pneumonia in critically ill patients". Eur J Epidemiol. 1991, 7: 320-327. 10.1007/BF00144995.CrossRefPubMed
8.
go back to reference Joshi N, Localio AR, Hamory BH: "A predictive risk index for nosocomial pneumonia in the intensive care unit". Am J Med. 1992, 93: 135-142. 10.1016/0002-9343(92)90042-A.CrossRefPubMed Joshi N, Localio AR, Hamory BH: "A predictive risk index for nosocomial pneumonia in the intensive care unit". Am J Med. 1992, 93: 135-142. 10.1016/0002-9343(92)90042-A.CrossRefPubMed
9.
go back to reference Rello J, Diaz E, Roque M, Vallés J: "Risk factors for developing pneumonia within 48 hours of intubation". Am J Respir Crit Care Med. 1999, 159: 1742-46.CrossRefPubMed Rello J, Diaz E, Roque M, Vallés J: "Risk factors for developing pneumonia within 48 hours of intubation". Am J Respir Crit Care Med. 1999, 159: 1742-46.CrossRefPubMed
10.
go back to reference Sirvent JM, Torres A, Vidaur L, Armengol J, de Batle J, Bonet A: "Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factors for developing early-onset ventilator-associated pneumonia". Intensive Care Med. 2000, 26 (9): 1369-72. 10.1007/s001340000611.CrossRefPubMed Sirvent JM, Torres A, Vidaur L, Armengol J, de Batle J, Bonet A: "Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factors for developing early-onset ventilator-associated pneumonia". Intensive Care Med. 2000, 26 (9): 1369-72. 10.1007/s001340000611.CrossRefPubMed
11.
go back to reference Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM: "A time-dependent analysis in intensive care unit pneumonia in trauma patients". J Trauma. 2004, 56: 296-303.CrossRefPubMed Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM: "A time-dependent analysis in intensive care unit pneumonia in trauma patients". J Trauma. 2004, 56: 296-303.CrossRefPubMed
12.
go back to reference Bronchard R, Albaladejo P, Brezac G, Geffroy A, Seince PF, Morris W, Branger C, Marty J: "Early onset pneumonia – risk factors and consequences in head trauma patients". Anesthesiology. 2004, 100: 234-9. 10.1097/00000542-200402000-00009.CrossRefPubMed Bronchard R, Albaladejo P, Brezac G, Geffroy A, Seince PF, Morris W, Branger C, Marty J: "Early onset pneumonia – risk factors and consequences in head trauma patients". Anesthesiology. 2004, 100: 234-9. 10.1097/00000542-200402000-00009.CrossRefPubMed
13.
go back to reference Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C: "Ventilator-associated pneumonia caused by potentially drug-resistant bacteria". Am J Respir Crit Care Med. 1998, 157 (2): 531-9.CrossRefPubMed Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C: "Ventilator-associated pneumonia caused by potentially drug-resistant bacteria". Am J Respir Crit Care Med. 1998, 157 (2): 531-9.CrossRefPubMed
14.
go back to reference Torres A, Anzar R, Gatell JM, Jiménez P, González J, Ferrer A, Celis R, Rodriguez-Roisin R: "Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients". Am Ver Respir Dis. 1990, 142: 523-528.CrossRef Torres A, Anzar R, Gatell JM, Jiménez P, González J, Ferrer A, Celis R, Rodriguez-Roisin R: "Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients". Am Ver Respir Dis. 1990, 142: 523-528.CrossRef
15.
go back to reference Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, Minopoulos GI, Zakynthinos S, Manolas KI: "Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria". Intensive Care Med. 2005, 31 (11): 1488-94. 10.1007/s00134-005-2697-y.CrossRefPubMed Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, Minopoulos GI, Zakynthinos S, Manolas KI: "Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria". Intensive Care Med. 2005, 31 (11): 1488-94. 10.1007/s00134-005-2697-y.CrossRefPubMed
16.
go back to reference Alvarez-Lerma F: "Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group". Intensive Care Med. 1996, 22 (5): 387-94. 10.1007/BF01712153.CrossRefPubMed Alvarez-Lerma F: "Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group". Intensive Care Med. 1996, 22 (5): 387-94. 10.1007/BF01712153.CrossRefPubMed
Metadata
Title
A case-control study on risk factors for early-onset respiratory tract infection in patients admitted in ICU
Authors
Teresa C Cardoso
Luís M Lopes
António H Carneiro
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2007
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-7-12

Other articles of this Issue 1/2007

BMC Pulmonary Medicine 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine